"Warehoused" Hepatitis C Patients May Boost Merck & Co., Inc., Johnson & Johnson, Vertex Pharmaceuticals (CA)
Bloomberg -- At Fred Poordad’s bustling hepatitis C clinic in the heart of Los Angeles, one in every five patients receives no treatment. They are waiting for a wave of new drugs, expected in the next 18 months, that may boost their chance at a cure by as much as 10-fold.